# China NMPA Drug Inspection - Hainan General Kangli Pharmaceutical Co., Ltd. - Clindamycin Phosphate for Injection

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hainan-general-kangli-pharmaceutical-co-ltd/e10b4e96-b08c-4c86-96d1-50f4db3f1735/
Source feed: China

> China NMPA drug inspection for Hainan General Kangli Pharmaceutical Co., Ltd. published September 21, 2018. Drug: Clindamycin Phosphate for Injection. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Jiangxi Province 2018 Drug Quality Bulletin
- Company Name: Hainan General Kangli Pharmaceutical Co., Ltd.
- Publication Date: 2018-09-21
- Drug Name: Clindamycin Phosphate for Injection

Company: https://www.globalkeysolutions.net/companies/hainan-general-kangli-pharmaceutical-co-ltd/8839a719-5540-4150-a9bc-a278c45738e7/